ERIC PETERSEN: Open Payments
NPI 1538149042 · MAQUOKETA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 31 payments from 11 companies in 2025. Trend: 2023 $208 · 2024 $453 · 2025 $752
Food & beverage: $531Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $234 |
| PFIZER INC. | 10 | $184 |
| Lilly USA, LLC | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| ABBVIE INC. | 2 | $59 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: PREVNAR 20, JARDIANCE, ELIQUIS, QULIPTA, MOUNJARO, Ozempic, BREZTRI, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
